Loading company…
multiBIND biotec GmbH develops bioDECONT, a biological decontamination agent for removing unwanted nucleic acid contamination.
Founded in 2005 in Cologne, Germany, multiBIND biotec GmbH develops decontamination and disinfection solutions, led by CEO Thomas Lisowsky. Its flagship bioDECONT is licensed to manufacturers for use in laboratories, industrial settings and healthcare facilities. The company raised EUR 0.63 mn in a Seed round in July 2008, co-led by AppliChem GmbH and High-Tech Gruenderfonds, and reported revenue of EUR 626,094.80 in 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in